Fulvestrant in the treatment of postmenopausal women with advanced breast cancer-Reference-Cited by-同舟云学术

Fulvestrant in the treatment of postmenopausal women with advanced breast cancer

Published:2005-06 Issue:3 Volume:5 Page:445-453
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Gradishar William

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1586/14737140.5.3.445

Reference41 articles.

1. Estrogen Receptor Breast Cancer Phenotypes in the Surveillance, Epidemiology, and End Results Database

2. Tamoxifen for early breast cancer: an overview of the randomised trials

3. Buzdar AU, Macahilig C. Treatment of early breast cancer: changing clinical practice. Poster presented atAromatase, Edinburgh, UK, 6–8 September (2004).

4. Anastrozole has a protective effect on the endometrium: data from the ATAC (‘Arimidex’, Tamoxifen, alone or in combination) trial

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision oncology: neither a silver bullet nor a dream;Pharmacogenomics;2017-11

2. A randomized trial to assess the biological activity of short-term (pre-surgical) fulvestrant 500 mg plus anastrozole versus fulvestrant 500 mg alone or anastrozole alone on primary breast cancer;Breast Cancer Research;2013-03-05

3. New Insights on Estrogen Receptor Actions in Hormone-Responsive Breast Cancer Cells by Interaction Proteomics;Cell and Molecular Biology of Breast Cancer;2013

4. The economic burden of metastatic breast cancer: A systematic review of literature from developed countries;Cancer Treatment Reviews;2011-04

5. Update on fulvestrant for hormone receptor-positive advanced breast cancer;Community Oncology;2007-04